MOUNJARO 2.5MG 4 vials

Description

is a prescription medication containing tirzepatide, a GLP-1 and GIP receptor agonist. It is used for:​

Therapeutic Goods Administration (TGA)

Type 2 Diabetes Management: To improve blood sugar control in adults when combined with diet and exercise.​

Weight Management: Although not FDA-approved for weight loss, Mounjaro has shown significant weight reduction effects in clinical studies. ​

The 5 mg/0.5 mL vial is a single-dose vial intended for subcutaneous injection. Each vial contains 5 mg of tirzepatide in 0.5 mL of solution. ​

💉 How to Use Mounjaro® 5 mg/0.5 mL Vial
Preparation: Inspect the vial to ensure the solution is clear and colorless.​

Injection Site: Clean the skin at the injection site on your abdomen or thigh.​

Dosage: Withdraw 0.5 mL of the solution (equivalent to 5 mg of tirzepatide) into a syringe.​

Injection: Inject the solution subcutaneously as directed by your healthcare provider.​

Storage: Store unused vials in the refrigerator at 2°C to 8°C (36°F to 46°F). Do not freeze. Once opened, the vial should be used immediately and not stored for future use. ​